Waters Corporation (WAT) Stock Analysis
Falling Knife setup · Temp Headwind edge
Healthcare · Diagnostics & Research
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $302.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 5 days (event risk); Weak overall score: 4.9/10.
Waters Corporation designs, manufactures, and services liquid chromatography, mass spectrometry, and thermal analysis instruments for pharmaceutical, industrial, and food sciences customers. On Feb 9, 2026, Waters completed the $16.8B acquisition of BD's Biosciences and... Read more
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $302.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 5 days (event risk); Weak overall score: 4.9/10. Chart setup: Death cross, below all MAs, RSI 40, MACD bearish. Score 4.9/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSupplierkey subcontractors in Singapore10-K Item 1A: 'key subcontractors providing manufacturing and support that are located in Singapore'
Material Events(8-K, last 90d)
- 2026-02-09Item 1.01LOWOn Feb 9, 2026, Waters completed the $16.8B BDS Business Acquisition from Becton Dickinson via Reverse Morris Trust. Waters entered into Merger Agreement, Separation Agreement, Tax Matters Agreement, and Transition Services Agreements. BD shareholders received ~38.5M Waters shares (~39.2% of combined company).SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $302.80 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 5 days (event risk); Weak overall score: 4.9/10. Chart setup: Death cross, below all MAs, RSI 40, MACD bearish. Prior stop was $279.51. Score 4.9/10, moderate confidence.
Take-profit target: $346.95 (+15.4% upside). Prior stop was $279.51. Stop-loss: $279.51.
Earnings in 5 days (event risk); Weak overall score: 4.9/10; Weak growth.
Waters Corporation trades at a P/E of 27.2 (forward 17.9). TrendMatrix value score: 5.2/10. Verdict: Sell.
28 analysts cover WAT with a consensus score of 3.9/5. Average price target: $386.
What does Waters Corporation do?Waters Corporation designs, manufactures, and services liquid chromatography, mass spectrometry, and thermal analysis...
Waters Corporation designs, manufactures, and services liquid chromatography, mass spectrometry, and thermal analysis instruments for pharmaceutical, industrial, and food sciences customers. On Feb 9, 2026, Waters completed the $16.8B acquisition of BD's Biosciences and Diagnostic Solutions (BDS), expanding into clinical diagnostics and flow cytometry.